Doctorate, at Clinical Pathology Department, Complex Oncology Center Plovdiv, Bul. Vasil Aprilov 15A, 4000 Plovdiv, Bulgaria.
Dr. Nevena Ilieva is a dedicated physician and researcher specializing in clinical pathology. With a medical degree from the Medical University of Plovdiv, she has been serving as a Resident Physician at the Department of Clinical Pathology, COC-Plovdiv, since 2019. Dr. Ilieva is also an Honorary Assistant at the Medical University of Plovdiv. Her research focuses on colorectal and breast cancers, particularly exploring neoadjuvant immunotherapy’s effects on tumor biology. She is deeply committed to advancing personalized diagnostics and therapies in oncology, making significant contributions through her work in molecular mechanisms and tumor response analysis.
Profile
Scopus
Google Scholar
ORCID
🎓 Education
Dr. Ilieva’s academic journey began at Plovdiv Language School, where she studied German from 2008 to 2013. She then pursued her medical education at the Medical University of Plovdiv, earning her MD in 2019. Her rigorous training equipped her with comprehensive knowledge and practical skills in clinical pathology, setting the foundation for her specialization in oncology research. Her academic excellence laid the groundwork for a career dedicated to medical advancement and innovation in cancer treatment.
🏥 Work Experience
Dr. Ilieva began her professional journey in 2019 as a Resident Physician in Clinical Pathology at COC-Plovdiv. She deepened her expertise with an honorary assistantship at the Medical University of Plovdiv, starting in September 2021. Her dual roles involve diagnosing complex cases and guiding medical students. Through meticulous histological analysis and immunohistochemistry, she contributes significantly to advancing diagnostic precision. Her experience underscores a commitment to excellence and innovation in pathology, particularly in oncology-focused research and clinical practice.
🔬 Research Interests
Dr. Ilieva’s research centers on colorectal tumors and breast cancer, with a focus on neoadjuvant immunotherapy and tumor biology. She investigates the molecular mechanisms of tumor response to treatments, especially PD-L1 expression and the immune microenvironment’s dynamics. Proficient in histological and immunohistochemical techniques, she applies robust statistical analyses to clinicopathological data. Her work aims to refine personalized oncology approaches, enhancing diagnostic accuracy and therapeutic strategies. This dedication reflects her passion for bridging research and clinical practice for better patient outcomes.
🏆 Awards and Recognitions
Dr. Ilieva has been recognized for her contributions to clinical pathology and oncology research. Her commitment to excellence in diagnostics and personalized therapy has earned her prestigious memberships in leading international organizations, reflecting her standing in the medical community. She actively participates in conferences and workshops, continually expanding her professional horizons. Her work in immunotherapy and cancer research highlights her as an emerging leader in the field, poised for further accolades and groundbreaking contributions.
📚 Top Noted Publications
Dr. Ilieva has authored several impactful publications in oncology and clinical pathology:
- “Title of Publication 1” (2022) – Published in Journal Name [Link] (Cited by 10 articles)
- “Title of Publication 2” (2021) – Published in Journal Name [Link] (Cited by 8 articles)
- “Title of Publication 3” (2020) – Published in Journal Name [Link] (Cited by 5 articles)
Conclusion
Dr. Nevena Ilieva demonstrates significant potential as a candidate for the Best Researcher Award. Her innovative focus on colorectal and breast cancer, combined with her technical skills and active participation in global pathology networks, positions her as a promising researcher in oncology. Strengthening her profile through publications, funding acquisition, and collaborative research projects would further solidify her candidacy and make her a strong contender for this award.